Document Detail


HLA-G: a human pregnancy-related immunomodulator.
MedLine Citation:
PMID:  19570712     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In human pregnancies mothers and their embryo/fetuses are invariably genetically different. Thus, attenuation of the adaptive maternal immune response, which is programmed to reject 'foreign' entities, is required for pregnancy to be initiated and maintained. Unexpectedly, given the propensity of the immune system to dispose of non-self entities, at least 50% of expected human pregnancies reliably go forward. This indicates that to a large extent, effective systems of tolerance have evolved. Although overlapping and redundant mechanisms of tolerance have been identified, production of HLA-G by trophoblast cells derived from the external trophectoderm layer of the blastocyst appears to be of major importance. At this point in time, no pregnancies in which all of the proteins derived from the HLA-G gene are absent have as yet been reported. Many studies have shown that both membrane-bound and soluble isoforms of the proteins derived from this HLA class Ib gene are produced by placental trophoblast cells, with consequences that include but are not restricted to immune suppression at the maternal-fetal interface. Here we report new studies that are leading to a better understanding of the HLA-G proteins, their unique structures, unusual modes of regulation, diverse functions, and potential for use in diagnostic and therapeutic procedures related to suboptimal fertility in women.
Authors:
Joan S Hunt; Daudi L Langat
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2009-06-29
Journal Detail:
Title:  Current opinion in pharmacology     Volume:  9     ISSN:  1471-4973     ISO Abbreviation:  Curr Opin Pharmacol     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-24     Completed Date:  2010-05-18     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  100966133     Medline TA:  Curr Opin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  462-9     Citation Subset:  IM    
Affiliation:
Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, United States. jhunt@kumc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood,  chemistry,  metabolism
Female
Fertility / immunology
HLA Antigens / blood,  chemistry,  metabolism,  physiology*
HLA-G Antigens
Histocompatibility Antigens Class I / blood,  chemistry,  metabolism,  physiology*
Humans
Immunologic Factors / metabolism,  physiology*
Maternal-Fetal Exchange / immunology*
Pregnancy / blood,  immunology*
Grant Support
ID/Acronym/Agency:
HD04940/HD/NICHD NIH HHS; HD24212/HD/NICHD NIH HHS; P01 HD049480-01A2/HD/NICHD NIH HHS; P01 HD049480-01A2S1/HD/NICHD NIH HHS; P01 HD049480-02/HD/NICHD NIH HHS; P01 HD049480-020001/HD/NICHD NIH HHS; P01 HD049480-03/HD/NICHD NIH HHS; R01 HD024212-14/HD/NICHD NIH HHS; R01 HD024212-15/HD/NICHD NIH HHS; R01 HD024212-16/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/HLA Antigens; 0/HLA-G Antigens; 0/Histocompatibility Antigens Class I; 0/Immunologic Factors
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The true diversity of devescovinid flagellates in the termite Incisitermes marginipennis.
Next Document:  Lung cancer and inflammation: interaction of chemokines and hnRNPs.